Skip to main content
Guidance

A visual guide to vaccines for the routine vaccination programme

Updated 24 September 2026

© Crown copyright 2026

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/a-visual-guide-to-vaccines/a-visual-guide-to-vaccines-for-the-routine-vaccination-programme

Infanrix hexa or Vaxelis

Infanrix hexa and Vaxelis packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
Infanrix hexa (GSK)
or
Vaxelis (Sanofi Pasteur) Hexavalent vaccine DTaP/IPV/Hib/HepB		 Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B 8, 12, 16 weeks and 18 months

Rotarix

Rotarix packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
Rotarix (GSK) Rotavirus (oral) Rotavirus gastroenteritis 8 weeks and 12 weeks

Bexsero

Bexsero packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
Bexsero (GSK) MenB Meningococcal group B 8 weeks, 12 weeks and 1 year

Prevenar 13

Prevenar 13 packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
Prevenar 13 (Pfizer) PCV Pneumococcal (13 serotypes) 16 weeks and 1 year

ProQuad (MSD) or Priorix Tetra

ProQuad packaging

Priorix-Tetra packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
ProQuad (MSD)
or
Priorix Tetra (GSK)
MMRV		 Measles, mumps, rubella and varicella Routinely at 1 year and 18 months for children born on or after 1 January 2025
Children born between 1 January 2020 and 31 December 2024 are also eligible for MMRV [footnote 1]

Boostrix-IPV or REPEVAX

Boostrix-IPV packaging

Repevax packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
Boostrix-IPV (GSK)
or
REPEVAX (Sanofi) dTaP/IPV 		Diphtheria, tetanus, pertussis and polio 3 years, 4 months

Gardasil 9

Gardasil packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
Gardasil 9 (MSD) HPV Cancers and genital warts caused by specific human papillomavirus (HPV) types Boys and girls aged 12 to 13 years (school Year 8)

REVAXIS

Revaxis packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
REVAXIS (Sanofi Pasteur) Td/IPV Tetanus, diphtheria and polio 14 years (school Year 9)

MenQuadfi

MenQuadfi packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
MenQuadfi (Sanofi) MenACWY Meningococcal groups A, C, W and Y 14 years (school Year 9)

ADACEL

Adacel packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
ADACEL (Sanofi) Tdap Tetanus, diphtheria and pertussis (whooping cough) Pregnant women from 16 weeks gestation

Abrysvo

Abrysyo packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
Abrysvo (Pfizer) RSV Respiratory syncytial virus Pregnant women from 28 weeks gestation.
75 years and above.
Those aged 65 to 74 years in certain clinical risk groups [footnote 2].
All adult residents in care homes for older adults [footnote 2].

Prevenar 20 or Pneumovax 23

Prevenar 20 packaging

Pneumovax 23 packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
Prevenar 20 (Pfizer) Pneumococcal conjugate vaccine (PCV20)
(Alternatively, for over 65 year olds only, Pneumovax 23 (MSD) Pneumococcal polysaccharide vaccine (PPV23), if locally available)		 Pneumococcal (20 or 23 serotypes) 65 years (and certain clinical risk groups) [footnote 3]

Shingrix

Shingrix packaging

Vaccine trade name, manufacturer, abbreviation Diseases protected against Age due
Shingrix (GSK) Shingles Shingles 18 years of age and older if severely immunosuppressed (no upper age limit)
65 years or 70 years of age [footnote 4] (remain eligible until their 80th birthday)

Full schedule

Read full details of the routine immunisation schedule.

References

  1. See: MMRV vaccination programme ↩

  2. See: RSV vaccination programme ↩ ↩2

  3. See: The Green Book: Pneumococcal chapter ↩

  4. See Shingles: guidance and vaccination programme ↩

Back to top